-
Study aim
-
Comparison of Goal Directed fluid therapy (GDFT) through Plethysmographic Variability Index (PVI) in plastic surgeries based on the Accelerated Recovery of Patients After Surgery (ERAS) protocol.
-
Design
-
A clinical trial with a control group, with parallel groups, randomized, on 72 patients
-
Settings and conduct
-
In patients undergoing surgery (abdominoplasty, mammoplasty) in the plastic department of Sina Hospital, comparing targeted fluid therapy based on the PVI index and the Traditional method, a double-blind randomized trial, in which the researcher and the patient were blinded.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: People over 18 years of age and without a history of specific diseases, who refer to Sinai Hospital for plastic and cosmetic surgeries such as abdominoplasty, mammoplasty, and facelift, will be included in the study.
Exclusion criteria: people who are undergoing surgeries other than cosmetic or day care surgeries, patients under 18 years old, people with a history of underlying diseases, patients with cardiac arrhythmia, cardiac ejection fraction ≤30% , pulmonary diseases interfering with mechanical ventilation and patients with chronic kidney failure and patients who experience massive bleeding during surgery that requires blood transfusion, the duration of the operation will not be less than 2 hours will not be included in the study.
-
Intervention groups
-
The intervention group (36 patients) includes targeted fluid therapy (GDFT) based on the PVI index with the aim of keeping the index below 13%.
The control group (36 patients) includes patients whose fluid therapy is traditional during the operation (4cc/Kg/h).
-
Main outcome variables
-
effect of fluid therapy; pain; nausea and vomiting; fatigue and sleepiness; constipation; tendency to discharge; wound site infection; wound site dehisence comparing the intervention group with the control group